Company: APXIF
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065703
Chunk: 658

Company: APx Acquisition Corp. I
Filing Date: 2025-07-18
Form: F-4/A
Chunk 658
---
              |     |                                |     | 140,910 |      |

____________ (i)Detail of contributions:

|                                      |     | For the six-month period ended 
                   December 31, 
                           2024 |     |    2023 |
|:-------------------------------------|:----|-------------------------------:|:----|--------:|
| Expenses paid on behalf of the Group |     |                        214,443 |     | 140,910 |
| Contributions                        |     |                        196,508 |     |       — |
| Total                                |     |                        410,951 |     | 140,910 |

Expenses paid on behalf of the Group:The contributions made by Heritas Ltd. during the six -monthperiods ended December 31, 2024 and 2023, primarily relate to operating costs, including management and director compensation, maintenance costs for laboratory equipment, medical genetics platform expenses and legal fees. The amounts for both periods are included within the Share Premium account in the interim Combined Statements of Changes in Shareholders’ Deficit.

F-112

Notes to Unaudited Interim Condensed Combined Financial Statements (Amounts in US Dollars, except otherwise indicated) 20.Related parties (cont.) Contributions:During the six -monthperiod ended December 31, 2024, various contributions were made by Heritas Ltd. as follows, and recorded in Share Premium within equity:

| Cash contribution     |     | US$ | 101,934 |      |
| In kind contributions |     | US$ |  94,574 | ​(i) |

____________ (i)Includes mainly inventory (reagents, which were acquired by parent on behalf of the group in exchange for share based instruments of the parent) and lease agreements (Note 6). Share -BasedIncentives: In addition to the direct contributions described above, Heritas Ltd. provided share -basedincentives amounting to US$174,920 during the six -monthperiod ended December 31, 2024. This represents the fair value of equity instruments issued under the Parent Company’s share -basedpayment arrangements and is recognized in the Combined Income Statement under “General and Administrative Expenses”. The corresponding increase is recorded in the Share premium within equity. b)Loans: The Group has received financial support through loans provided by its shareholders and other related parties. Below is a detailed breakdown of the composition of these loans:

| Lender           |     | December 31,